GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Degree of Financial Leverage

Fresenius SE KGaA (Fresenius SE KGaA) Degree of Financial Leverage : 4.01 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Fresenius SE KGaA's Degree of Financial Leverage for the quarter that ended in Dec. 2023 was 4.01. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Fresenius SE KGaA's Degree of Financial Leverage or its related term are showing as below:

FSNUY's Degree of Financial Leverage is ranked worse than
93.49% of 630 companies
in the Healthcare Providers & Services industry
Industry Median: 1.02 vs FSNUY: 4.01

Fresenius SE KGaA Degree of Financial Leverage Historical Data

The historical data trend for Fresenius SE KGaA's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Degree of Financial Leverage Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 1.44 -1.54 0.46 4.01

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 12.17 7.51 -9.47 4.01

Competitive Comparison of Fresenius SE KGaA's Degree of Financial Leverage

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Degree of Financial Leverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Degree of Financial Leverage falls into.



Fresenius SE KGaA Degree of Financial Leverage Calculation

Fresenius SE KGaA's Degree of Financial Leverage for the quarter that ended in Dec. 2023 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( -0.286 (Dec. 2023) / 0.646 (Dec. 2022) - 1 )/( 1362.05 (Dec. 2023) / 2057.203 (Dec. 2022) - 1 )
=-1.4427/-0.3379
=4.27***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Fresenius SE KGaA  (OTCPK:FSNUY) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Fresenius SE KGaA Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 05-04-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 06-01-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 05-04-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran 04-13-2021